Evidence map›Paper›PMID 30241176›Full record

ArticleJournal of global oncology2018

Leverage of an Existing Cervical Cancer Prevention Service Platform to Initiate Breast Cancer Control Services in Zambia: Experiences and Early Outcomes.

Leeya F Pinder, Ronda Henry-Tillman, David Linyama, Victor Kusweje, Jean-Baptiste Nzayisenga, Aaron Shibemba, Vikrant Sahasrabuddhe, Kennedy Lishimpi, Mulindi Mwanahamuntu, Michael Hicks and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of global oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Observational
  9. Article
  10. To parachute or not.Ecancermedicalscience · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Leeya F PinderLeeva F. Pinder, David Linyama, Jean-Baptiste Nzayisenga, Aaron Shibemba, Mulindi Mwanahamuntu, and Groesbeck P. Parham, University of Zambia School of Medicine; Kennedy Lishimpi, Cancer Diseases Hospital, Lusaka; Victor Kusweje, Kabwe General Hospital, Kabwe, Zambia; Leeya F. Pinder, Michael Hicks, and Groesbeck P. Parham, University of North Carolina at Chapel Hill, Chapel Hill, NC; Ronda Henry-Tillman, University of Arkansas for Medical Sciences, Little Rock, AR; and Vikrant Sahasrabuddhe, National Cancer Institute, Bethesda, MD.
Ronda Henry-TillmanLeeva F. Pinder, David Linyama, Jean-Baptiste Nzayisenga, Aaron Shibemba, Mulindi Mwanahamuntu, and Groesbeck P. Parham, University of Zambia School of Medicine; Kennedy Lishimpi, Cancer Diseases Hospital, Lusaka; Victor Kusweje, Kabwe General Hospital, Kabwe, Zambia; Leeya F. Pinder, Michael Hicks, and Groesbeck P. Parham, University of North Carolina at Chapel Hill, Chapel Hill, NC; Ronda Henry-Tillman, University of Arkansas for Medical Sciences, Little Rock, AR; and Vikrant Sahasrabuddhe, National Cancer Institute, Bethesda, MD.
David LinyamaLeeva F. Pinder, David Linyama, Jean-Baptiste Nzayisenga, Aaron Shibemba, Mulindi Mwanahamuntu, and Groesbeck P. Parham, University of Zambia School of Medicine; Kennedy Lishimpi, Cancer Diseases Hospital, Lusaka; Victor Kusweje, Kabwe General Hospital, Kabwe, Zambia; Leeya F. Pinder, Michael Hicks, and Groesbeck P. Parham, University of North Carolina at Chapel Hill, Chapel Hill, NC; Ronda Henry-Tillman, University of Arkansas for Medical Sciences, Little Rock, AR; and Vikrant Sahasrabuddhe, National Cancer Institute, Bethesda, MD.
Victor KuswejeLeeva F. Pinder, David Linyama, Jean-Baptiste Nzayisenga, Aaron Shibemba, Mulindi Mwanahamuntu, and Groesbeck P. Parham, University of Zambia School of Medicine; Kennedy Lishimpi, Cancer Diseases Hospital, Lusaka; Victor Kusweje, Kabwe General Hospital, Kabwe, Zambia; Leeya F. Pinder, Michael Hicks, and Groesbeck P. Parham, University of North Carolina at Chapel Hill, Chapel Hill, NC; Ronda Henry-Tillman, University of Arkansas for Medical Sciences, Little Rock, AR; and Vikrant Sahasrabuddhe, National Cancer Institute, Bethesda, MD.
Jean-Baptiste NzayisengaLeeva F. Pinder, David Linyama, Jean-Baptiste Nzayisenga, Aaron Shibemba, Mulindi Mwanahamuntu, and Groesbeck P. Parham, University of Zambia School of Medicine; Kennedy Lishimpi, Cancer Diseases Hospital, Lusaka; Victor Kusweje, Kabwe General Hospital, Kabwe, Zambia; Leeya F. Pinder, Michael Hicks, and Groesbeck P. Parham, University of North Carolina at Chapel Hill, Chapel Hill, NC; Ronda Henry-Tillman, University of Arkansas for Medical Sciences, Little Rock, AR; and Vikrant Sahasrabuddhe, National Cancer Institute, Bethesda, MD.
Aaron ShibembaLeeva F. Pinder, David Linyama, Jean-Baptiste Nzayisenga, Aaron Shibemba, Mulindi Mwanahamuntu, and Groesbeck P. Parham, University of Zambia School of Medicine; Kennedy Lishimpi, Cancer Diseases Hospital, Lusaka; Victor Kusweje, Kabwe General Hospital, Kabwe, Zambia; Leeya F. Pinder, Michael Hicks, and Groesbeck P. Parham, University of North Carolina at Chapel Hill, Chapel Hill, NC; Ronda Henry-Tillman, University of Arkansas for Medical Sciences, Little Rock, AR; and Vikrant Sahasrabuddhe, National Cancer Institute, Bethesda, MD.
Vikrant SahasrabuddheLeeva F. Pinder, David Linyama, Jean-Baptiste Nzayisenga, Aaron Shibemba, Mulindi Mwanahamuntu, and Groesbeck P. Parham, University of Zambia School of Medicine; Kennedy Lishimpi, Cancer Diseases Hospital, Lusaka; Victor Kusweje, Kabwe General Hospital, Kabwe, Zambia; Leeya F. Pinder, Michael Hicks, and Groesbeck P. Parham, University of North Carolina at Chapel Hill, Chapel Hill, NC; Ronda Henry-Tillman, University of Arkansas for Medical Sciences, Little Rock, AR; and Vikrant Sahasrabuddhe, National Cancer Institute, Bethesda, MD.
Kennedy LishimpiLeeva F. Pinder, David Linyama, Jean-Baptiste Nzayisenga, Aaron Shibemba, Mulindi Mwanahamuntu, and Groesbeck P. Parham, University of Zambia School of Medicine; Kennedy Lishimpi, Cancer Diseases Hospital, Lusaka; Victor Kusweje, Kabwe General Hospital, Kabwe, Zambia; Leeya F. Pinder, Michael Hicks, and Groesbeck P. Parham, University of North Carolina at Chapel Hill, Chapel Hill, NC; Ronda Henry-Tillman, University of Arkansas for Medical Sciences, Little Rock, AR; and Vikrant Sahasrabuddhe, National Cancer Institute, Bethesda, MD.
Mulindi MwanahamuntuLeeva F. Pinder, David Linyama, Jean-Baptiste Nzayisenga, Aaron Shibemba, Mulindi Mwanahamuntu, and Groesbeck P. Parham, University of Zambia School of Medicine; Kennedy Lishimpi, Cancer Diseases Hospital, Lusaka; Victor Kusweje, Kabwe General Hospital, Kabwe, Zambia; Leeya F. Pinder, Michael Hicks, and Groesbeck P. Parham, University of North Carolina at Chapel Hill, Chapel Hill, NC; Ronda Henry-Tillman, University of Arkansas for Medical Sciences, Little Rock, AR; and Vikrant Sahasrabuddhe, National Cancer Institute, Bethesda, MD.
Michael HicksLeeva F. Pinder, David Linyama, Jean-Baptiste Nzayisenga, Aaron Shibemba, Mulindi Mwanahamuntu, and Groesbeck P. Parham, University of Zambia School of Medicine; Kennedy Lishimpi, Cancer Diseases Hospital, Lusaka; Victor Kusweje, Kabwe General Hospital, Kabwe, Zambia; Leeya F. Pinder, Michael Hicks, and Groesbeck P. Parham, University of North Carolina at Chapel Hill, Chapel Hill, NC; Ronda Henry-Tillman, University of Arkansas for Medical Sciences, Little Rock, AR; and Vikrant Sahasrabuddhe, National Cancer Institute, Bethesda, MD.
Groesbeck P ParhamLeeva F. Pinder, David Linyama, Jean-Baptiste Nzayisenga, Aaron Shibemba, Mulindi Mwanahamuntu, and Groesbeck P. Parham, University of Zambia School of Medicine; Kennedy Lishimpi, Cancer Diseases Hospital, Lusaka; Victor Kusweje, Kabwe General Hospital, Kabwe, Zambia; Leeya F. Pinder, Michael Hicks, and Groesbeck P. Parham, University of North Carolina at Chapel Hill, Chapel Hill, NC; Ronda Henry-Tillman, University of Arkansas for Medical Sciences, Little Rock, AR; and Vikrant Sahasrabuddhe, National Cancer Institute, Bethesda, MD.
University Teaching Hospital · ZMNational Cancer Institute · USUniversity of North Carolina at Chapel Hill · US

Funding

Fogarty Global Health Fellows Coordinating CenterR25TW009340 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CHI, BENJAMIN H. · 2012 to 2016
$6.9M
UNC Global Women’s Health FellowshipT32HD075731 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CHI, BENJAMIN H. · 2013 to 2024
$2.4M
FIC NIH HHS R25 TW009340NICHD NIH HHS T32 HD075731
6 · The paper itself

Abstract

purposeIn 2005, the Cervical Cancer Prevention Program in Zambia (CCPPZ) was implemented and has since provided cervical cancer screen-and-treat services to more than 500,000 women. By leveraging the successes and experiences of the CCPPZ, we intended to build capacity for the early detection and surgical treatment of breast cancer.

methodsOur initiative sought to build capacity for breast cancer care through the (1) formation of a breast cancer advocacy alliance to raise awareness, (2) creation of resource-appropriate breast cancer care training curricula for mid- and high-level providers, and (3) implementation of early detection and treatment capacity within two major health care facilities.

resultsSix months after the completion of the initiative, the following outcomes were documented: Breast health education and clinical breast examination (CBE) services were successfully integrated into the service platforms of four CCPPZ clinics. Two new breast diagnostic centers were opened, which provided access to breast ultrasound, ultrasound-guided core needle biopsy, and needle aspiration. Breast health education and CBE were provided to 1,955 clients, 167 of whom were evaluated at the two diagnostic centers; 55 of those evaluated underwent core-needle biopsy, of which 17 were diagnosed with invasive cancer. Newly trained surgeons performed six sentinel lymph node mappings, eight sentinel lymph node dissections, and 10 breast conservation surgeries (lumpectomies).

conclusionThis initiative successfully established clinical services in Zambia that are critical for the early detection and surgical management of breast cancer.

Indexed as

AdultBreast NeoplasmsEarly Detection of CancerFemaleHumansMiddle AgedUterine Cervical NeoplasmsZambia

Identifiers

PMID30241176
PMCPMC6180756
OpenAlexW2752341119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.